• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Healthcare·MLLAB.PA
Share

Media Lab S.p.A. Stocks

€ 3.2Last Updated 28.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 8.63M

€ 3.2
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Media Lab S.p.A. specializes in providing information technology solutions tailored for the dental industry. The company's offerings include Implant 3D, a sophisticated software designed for planning dental implants and generating surgical guides, which empowers users to conduct three-dimensional implant simulations directly on their personal computers. Furthermore, Media Lab S.p.A. supplies various instruments and accessories crucial for implantology and guided surgical techniques, as well as delivering professional training programs. Established in 1994, the company's headquarters are situated in Milan, Italy.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 21:35

Three Fed officials said interest rates need to be raised to combat inflation

31.07.2026 20:36

Nvidia Finds Itself in the Unfamiliar Role of an Undervalued Growth Stock — Morningstar

31.07.2026 19:29

"There's no end in sight to the rise in capital expenditures": The four Big Tech companies' investments in AI have already exceeded $1 trillion

31.07.2026 18:43

Profits at the two leading U.S. oil companies have skyrocketed. They've found a "weak spot."

31.07.2026 18:37

Novo Nordisk shares plummeted 10% after a heart drug trial failed

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026